Cochlear Limited
Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant.
| Company type | Public |
|---|---|
| |
| Industry | Biotechnology |
| Founded | 1981 |
| Headquarters | Sydney, Australia |
Key people | Dig Howitt (CEO) Ms Alison Deans (Chair) |
| Products | Cochlear implants Bone-anchored hearing aids Cochlear wireless accessories Bone anchored prosthetics |
| Revenue | A$1,240 million (2017) |
| A$224 million (2017) | |
Number of employees | 4,000 in 20 countries (2020) |
| Website | www.cochlear.com |
Based in Sydney, Cochlear was formed in 1981 as a subsidiary of Nucleus with finance from the Australian government to commercialise the implants pioneered by Dr. Graeme Clark, although the company later became separate. As of 2022, the company holds 50% of the cochlear implant market, with more than 250,000 people receiving one of Cochlear's implants as of 2015.
Cochlear was named Australia's most innovative company by the Intellectual Property Research Institute of Australia in 2002 and 2003, and one of the world's most innovative companies by Forbes in 2011.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.